Results 81 to 90 of about 1,055,290 (365)

Dual targeting of RET and SRC synergizes in RET fusion‐positive cancer cells

open access: yesMolecular Oncology, EarlyView.
Despite the strong activity of selective RET tyrosine kinase inhibitors (TKIs), resistance of RET fusion‐positive (RET+) lung cancer and thyroid cancer frequently occurs and is mainly driven by RET‐independent bypass mechanisms. Son et al. show that SRC TKIs significantly inhibit PAK and AKT survival signaling and enhance the efficacy of RET TKIs in ...
Juhyeon Son   +13 more
wiley   +1 more source

Correlation between levels of physical activity, disease severity and pain intensity in women with fibromyalgia

open access: yesBrJP
BACKGROUND AND OBJECTIVES: Currently, there is conflicting evidence regarding both physical activity and exercise in relation to the impact of fibromyalgia (FM).
Márcio Bruning   +5 more
doaj   +1 more source

Risk and protective factors for non communicable diseases in the Belo Horizonte population: Vigitel 2008

open access: yesRevista Brasileira de Epidemiologia, 2013
Introduction: The Non Communicable Diseases (NCD) are the main causes of death in, having known, avoidable the Risk Factor (RF) and susceptible to intervention.
Bruna Mara Duarte   +2 more
doaj   +1 more source

Stakeholder management through relationship management [PDF]

open access: yes, 2010
postprin
Koh, TY, Rowlinson, SM, Tuuli, MM
core  

Impact of Latest Technology in Mandalika MotoGP Tourism PR: SWOT Review

open access: yesINTERNATIONAL JOURNAL OF ECONOMICS, MANAGEMENT, BUSINESS, AND SOCIAL SCIENCE (IJEMBIS)
This study explores the integration of digital technology in tourism promotion, focusing on the transformative impact of social media, AI, and big data. Using qualitative methods and SWOT analysis, the paper discusses the challenges and opportunities in ...
D. Awaloedin   +3 more
semanticscholar   +1 more source

Chemical Synthesis and biochemical reactivity of bacterlophage bambda pRpromoter [PDF]

open access: yesNucleic Acids Research, 1983
By a combination of chemical and enzymatic methods, a 75 base pair DNA duplex containing the sequence of the lambda PR promoter including the OR1 and OR2 cI repressor binding sites was synthesized. The solid support phosphite triester procedure (Caruthers, M. H.
P L, deHaseth   +3 more
openaire   +2 more sources

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Integrated analysis of the role of PR/SET domain 14 in gastric cancer

open access: yesBMC Cancer
Gastric cancer is one of the most common tumors worldwide, and most patients are deprived of treatment options when diagnosed at advanced stages. PRDM14 has carcinogenic potential in breast and non-small cell lung cancer.
Xiao Li   +6 more
semanticscholar   +1 more source

Rho-dependent termination of transcription. II. Kinetics of mRNA elongation during transcription from the bacteriophage lambda PR promoter.

open access: yesJournal of Biological Chemistry, 1983
The kinetics of elongation of the mRNA that initiates from the lambda PR promoter has been examined using specific restriction fragments as template, and the locations at which significant pausing of the RNA polymerase occurs during in vitro transcription have been established.
W D, Morgan, D G, Bear, P H, von Hippel
openaire   +2 more sources

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

open access: yesMolecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy